COSMIC project: consensus on the objectives of the metabolic syndrome in clinic

Metabolic syndrome (MetS), a disorder with a high and growing prevalence, is a recognized risk factor for cardiovascular disease (CVD) and type 2 diabetes. It is a constellation of clinical and metabolic risk factors that include abdominal obesity, dyslipidemia, glucose intolerance, and hypertension...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes, metabolic syndrome and obesity metabolic syndrome and obesity, 2018-01, Vol.11, p.683-697
Main Authors: Pedro-Botet, Juan, Ascaso, Juan F, Barrios, Vivencio, De la Sierra, Alejandro, Escalada, Javier, Millán, Jesús, Mostaza, Jose M, Pérez-Martínez, Pablo, Pintó, Xavier, Salas-Salvadó, Jordi, Valdivielso, Pedro
Format: Article
Language:English
Subjects:
Abdomen
Arteriosclerosis
Aspirin
Cardiology
Cardiovascular disease
Cardiovascular diseases
cardiovascular prevention
Care and treatment
Clinical trials
Councils
Development and progression
Diabetes
diabetes prevention
Diabetes therapy
Disease prevention
Epidemiology
Esophagus
Fatty acids
Glucose
Glucose intolerance
Health risk assessment
Heart
Hospitals
Hypertension
Insulin
Insulin resistance
Internal medicine
Lipoproteins
Management
Medicine
Metabolic diseases
Metabolic disorders
Metabolic syndrome
Nutrition
Obesity
Review
Stroke
Systematic review
Task forces
Type 2 diabetes
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Metabolic syndrome (MetS), a disorder with a high and growing prevalence, is a recognized risk factor for cardiovascular disease (CVD) and type 2 diabetes. It is a constellation of clinical and metabolic risk factors that include abdominal obesity, dyslipidemia, glucose intolerance, and hypertension. Unfortunately, MetS is typically underrecognized, and there is great heterogeneity in its management, which can hamper clinical decision-making and be a barrier to achieving the therapeutic goals of CVD and diabetes prevention. Although no single treatment for MetS as a whole currently exists, management should be targeted at treating the conditions contributing to it and possibly reversing the risk factors. All this justifies the need to develop recommendations that adapt existing knowledge to clinical practice in our healthcare system. In this regard, professionals from different scientific societies who are involved in the management of the different MetS components reviewed the available scientific evidence focused basically on therapeutic aspects of MetS and developed a consensus document to establish recommendations on therapeutic goals that facilitate their homogenization in clinical decision-making.
ISSN:1178-7007
1178-7007
DOI:10.2147/DMSO.S165740